Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact surveillance

Data Availability

Data cannot be publicly shared because it contains potentially identifying information of human subjects. However, the data are available from the Scientific and Ethics Review Unit of Kenya Medical Research Institute (Email: seru{at}kemri.go.ke) for researchers who meet the criteria for access to confidential data.